lobbying_activities: 2681721
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2681721 | d33cbdb3-e5ba-4b28-b37c-423bb16c51f3 | Q3 | CME GROUP, INC. | 9033 | CME GROUP INC | 2021 | third_quarter | FIN | 1. Wall Street Reform and Consumer Protection Act (Dodd-Frank, PL 111-203) a. Title II: Issues related orderly liquidation authority b. Title VIII Payment Clearing and Settlement Supervision: Issues related to the regulation of systemically important financial market utilities 2. Issues related to the CFTC 3. Issues related to CFTC funding 4. Issues related to clearinghouse resolution and recovery | HOUSE OF REPRESENTATIVES,SENATE | 280000 | 0 | 0 | 2021-10-15T14:12:30.890000-04:00 |